The conference will highlight latest developments in the 3D cell culture field: Advanced cell culture models for understanding of diseases and substance testing. Success stories: clinical and industrial applications of 3D cell culture systems. Innovative enabling technologies.
In the following you can download the programme:
| 09:30 |
Registration |
|---|---|
| 10:30 | Welcome Address |
Effects of MicroenvironmentChair: H. Hauser¹; ¹ Helmholtz Centre for Infection Research, Braunschweig/D |
|
| 10:35 |
KeynoteEngineering organoid development |
| 11:20 | Macromolecular crowding in 2D and 3D culture systems: creating of cell and stem cell specific microenvironments M. Raghunath¹; N. Kohli¹; ¹ Zurich University of Applied Sciences, ICBT, Wädenswil/CH |
| 11:40 | Redefining cell culture environment with combinatorial biomatrices A. Thomas¹; ¹ B CUBE Center for Molecular Bioengineering, Center for Molecular and Cellular Bioengineering - TU Dresden,, Dresden/D |
| 12:00 | iPSC-derived neurospheroids recapitulate development and pathological signatures of brain microenvironment A. Terrasso¹; D. Simão¹; N. Bayó-Puxan²; F. Arez¹; M. Silva¹; M. Sousa¹; S. Creysells³; P. Gomes-Alves¹; N. Raimundo⁴; E. Kremer³; P. Alves¹; C. Brito¹; ¹ iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal; Instituto de Tecnologia Química e Biológica António Xavier, Universidede Nova de Lisboa, Oeiras, Portugal;, Oeiras/P; ² Institute of Biomedicine of the University of Barcelona (IBUB); Institut de Génétique Moléculaire de Montpellier, CNRS UMR 5535; Université de Montpellier, Barcelona; Montpellier/E; ³ Institut de Génétique Moléculaire de Montpellier, CNRS UMR 5535; Université de Montpellier, Montpellier/F; ⁴ Universitätsmedizin Göttingen, Institut für Zellbiochemie, Göttingen/D |
| 12:20 | Expansion of mouse pancreatic organoids in a chemically defined three-dimensional matrix N. Rischert¹; H. Wurst¹; T. Moreth²; L. Hof²; E. Stelzer²; M. Huch³; F. Pampaloni²; B. Angres¹; ¹ Cellendes GmbH, Reutlingen/D; ² Goethe-Universität Frankfurt am Main, Frankfurt am Main/D; ³ University of Cambridge, Cambridge/UK |
| 12:40 | Lunch Break / Posters / Exhibition |
Imaging and AnalyticsChair: R. Pörtner¹; ¹ Hamburg University of Technology/D |
|
| 14:00 |
Keynote
Observing three-dimensional biological specimens with |
| 14:45 | Image-based quantification of immunotherapies effects in 3D environment K. Yan¹; L. Daszkiewicz¹; L. Price¹; ¹ OcellO B.V., Leiden/NL |
| 15:05 | 3D culture models for investigaing recruitment of stem cells to the vascular niche Y. Atlas¹; C. Gorin2; C. Chaussain2; S. Germain1; L. Muller¹; ¹ CIRB, Collège de France, Paris/F; 2 Decartes University, Dental School, Paris/F |
| 15:25 | STATARRAYS©: microcavity arrays as a useful tool to detect single cell migration in a 4D co-culture model of human bone marrow E. Gottwald¹; S. Giselbrecht¹; R. Truckenmüller¹; V. Colditz²; C. Nies²; ¹ 300MICRONS GmbH, Karlsruhe/D; ² Karlsruhe Institute of Technology (KIT), Karlsruhe/D |
| 15:45 | Coffee Break / Posters / Exhibition |
Predictive Model SystemsChair: T. May¹; ¹InSCREENeX GmbH, Braunschweig/D |
|
| 16:15 |
Keynote3D human liver spheroid systems for analyses of liver diseases, liver function, drug metabolism and toxicity |
| 17:00 | Novel predictive 3D cultivation models for validating small molecules against KSHV infection T. Dubich¹; C. Lipps¹; T. May²; M. Stadler¹; T. Schulz³; D. Wirth¹; ¹ Helmholtz Centre for Infection Research, Braunschweig/D; ² InSCREENeX GmbH, Braunschweig/D; ³ Institute of Virology, Hannover Medical School, Hannover/D |
| 17:20 | Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance C. Bingel¹; E. Koeneke¹; J. Ridinger¹; A. Bittmann¹; M. Sill²; H. Peterziel¹; J. Wrobel¹; I. Rettig¹; T. Milde¹; U. Fernekorn³; F. Weise³; A. Schober³; O. Witt¹; I. Oehme⁴; ¹ CCU Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg/D; ² German Cancer Research Center DKFZ), Heidelberg/D; ³ Dpt of Nano-Biosystem Technology, TU Ilmenau, Ilmenau/D; ⁴ DKFZ Heidelberg, Heidelberg/D |
| 17:40 |
KeynoteSynthetic Biology-Inspired Treatment Strategies of the Future M. Fussenegger¹; ¹ ETH Zurich, Zurich/CH |
| 18:25 |
Poster Session / Poster Party (18:25 - 21:00) |
| 18:30 |
Section Member Assembly (Room K3+K4 / 18:30 - 19:30) |
| 08:30 |
Registration |
|---|---|
Advanced Models - From Liver to LUNG
Chair: M. Rimann¹; ¹ Zurich University of Applied Sciences, Wädenswil/CH |
|
| 09:00 | Metabolic cross talk between human pancreatic islet and liver spheroids in a microphysiological system - Towards a novel human ex vivo model of Type 2 Diabetes S. Bauer¹; C. Wennberg Huldt²; K. Kanebratt²; I. Durieux¹; D. Gunne¹; S. Andersson²; L. Ewart³; W. Haynes²; I. Maschmeyer¹; A. Winter¹; C. Ämmälä⁴; U. Marx¹; T. Andersson⁴; ¹ TissUse GmbH, Berlin/D; ² AstraZeneca, Mölndal/S; ³ AstraZeneca, Cambridge/UK; ⁴ AstraZeneca, Mölndal/D |
| 09:20 | Mimicking human physiology at Transwell-based barrier models of the proximal tubulus – The ZEBRA-Chip F. Schmieder¹; D. Förster²; M. Hempel¹; J. Sradnick²; B. Hohenstein²; F. Sonntag¹; ¹ Fraunhofer Institute for Material and Beam Technology IWS, Dresden/D; ² Division of Nephrology, Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden, Dresden/D |
| 09:40 |
Human and mouse intestinal organoids as model system for studying drug transport ¹ Technische Universität München, Freising/D; ²TUM ZIEL Institute for Food & Health, Freising/D; ³TUM Institute for Advanced Study, Garching/D; ⁴Dept. of Surgery, Klinikum rechts der Isar, München, Germany |
| 10:00 | Microstructured 3D model of small intestine epithelium: breaking the mold M. García-Díaz¹; A. G. Castaño¹; G. Altay¹; N. Torras¹; R. Martin-Venegas²; R. Ferrer¹; E. Martínez¹; ¹ Institute for Bioengineering of Catalonia, Barcelona/E; ² Universitat de Barcelona, Barcelona/E |
| 10:20 | Long-term culture of rat Precision-Cut Lung Slices using Lab-on-Chip technology as an ex vivo system with prolonged viability S. Konzok¹; S. Dehmel¹; V. Neuhaus¹; J. Labisch¹; S. Grünzner²; F. Sonntag²; A. Braun¹; K. Sewald¹; ¹ Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hannover/D; ² Fraunhofer Institute for Material and Beam Technology IWS / Dresden University of Technology, Dresden/D |
| 10:40 |
Coffee Break / Posters / Exhibition |
Safety and Toxicity TestingChair: U. Marx¹; ¹ TissUse GmbH, Berlin/D |
|
| 11:15 |
KeynoteAdvanced cell models, organs on a chip & microphysiological systems in drug safety assessment: the need, the vision – and challenges to overcome |
| 12:00 | A Novel 3D Human Liver Fibrosis Model for Anti-fibrotic Drug Discovery and Safety Testing P. Guye¹, S. Messner¹; ¹ Insphero AG, Schlieren/CH |
| 12:20 | Bioprinted kidney model to assess nephrotoxicity M. Nosswitz¹; M. Rimann²; N. Hernando³; C. Wagner³; U. Graf-Hausner¹; M. Raghunath¹; ¹ Zurich University of Applied Sciences, ICBT, Waedenswil/CH; ² Zurich University of Applied Sciences, ICBT, Wädenswil/CH; ³ University of Zurich, Zurich/CH |
| 12:40 | Microfluidic Platform for Advanced Embryotoxicity Testing in vitro J. Boos¹; A. Michlmayr¹; K. Renggli¹; O. Frey²; A. Hierlemann³; ¹ ETH Zürich, D-BSSE Basel, Basel/CH; ² Insphero AG, Schlieren/CH; ³ ETH Zürich, D-BSSE Basel, Basel/CH |
| 13:00 |
Closing remarks |
| 13:05 |
Lunch / Posters / Exhibition |
| 14:15 | End of the Conference |
Topic |
1.1 Advanced cell culture models |
|
P1.1.01 |
Advanced physiologically relevant 3D models for pre-clinical screening |
|
P1.1.02 |
Evaluation of EGFR induced on-target and target-mediated adverse effects in a microfluidic 3D human lung tumour – full thickness skin co-culture model |
|
P1.1.03 |
A 3D High-Content Screening assay as model system for polycystic kidney disease |
|
P1.1.04 |
Parallelized Heart-on-a-chip with integrated Force Sensing incorporating human iPS-derived cardiac microtissues |
|
P1.1.05 |
Establishment of an advanced in vitro model to study nanomaterial-intestinal barrier interactions |
|
P1.1.06 |
The Ocular DynaMiTES – A dynamic microfluidic in vitro system with improved predictability of ocular drug absorption |
|
P1.1.07 |
Cell Processing in Microreactors: Real-time Monitoring of Cell Metabolism Using Sensor Particles and Surface Based, Gentle Cell Detachment |
|
P1.1.08 |
Evaluation of a Novel Cell Culture Platform with Various Barrier Forming Cells for Dynamic Cultivation |
|
P1.1.09 |
Ready-to-use 3D spheroid culture as a standard tool |
|
P1.1.10 |
Dual targeting of prognostic biomarkers in the 3D microtumor model of advanced colorectal cancer |
|
P1.1.11 |
Permeation Measurement for 3D Skin Culture in a Membrane Insert System |
|
P1.1.12 |
Preservation of tumor architecture and heterogeneity in long-term cultures of patient-derived explants |
| P1.1.13 | Establishment of a murine intestinal tissue model based on immortalized primary epithelial cells C. Fey¹; T. Truschel²; M. Schweinlin¹; H. Walles³; T. May²; M. Metzger³ ¹ Department of Tissue Engineering and Regenerative Medicine (TERM), University Hospital Würzburg, Würzburg/D; ² InSCREENeX GmbH, Braunschweig/D; ³ Translational Center Würzburg “Regenerative Therapies for Oncology and Musculoskeletal Diseases” (TZKME), Würzburg branch of the Fraunhofer Institute of Silicate Research (ISC), Würzburg/D |
| P1.1.14 | Development of a human epidermal burn wound model V. Schneider¹; ¹ Uniklinik Würzburg, Würzburg/D |
| P1.1.15 | Initial screening of novel copolymer micelles for biocompatibility and effects on cell motility Y. Yordanov¹; D. Aluani¹; B. Tzankov¹; V. Tzankova¹; R. Kalinova²; I. Dimitrov³; V. Bankova⁴; M. Popova⁴; B. Trusheva⁴; K. Yoncheva¹ ¹ Faculty of Pharmacy, Medical University of Sofia, Sofia/BG; ² Institute of Polymers, Bulgarian Academy of Sciences, Sliven/BG; ³ Institute of Polymers, Bulgarian Academy of Sciences, Sofia/BG; ⁴ Institute of Organic Chemistry with Center for Phytochemistry, Bulgarian Academy of Sciences, Sofia/BG |
| P1.1.16 | An injectable hybrid hydrogel for tissue engineering applications R. Wittig¹; B. Baumann²; M. Lindén² ¹ Institute for Laser Technologies in Medicine & Metrology (ILM) at Ulm University, Ulm/D; ² Institute for Inorganic Chemistry II, Ulm University, Ulm/D |
| P1.1.17 | A tissue engineered Full Thickness Skin Equivalent based on a non-contracting, biophysical optimised collagen type-I hydrogel P. Fey¹; C. Reuter²; T. Finger¹; M. Engstler²; H. Walles³; F. Groeber-Becker¹ ¹ Fraunhofer ISC - Translationszentrum für Regenerative Therapien TLZ-RT, Würzburg/D; ² Julius-Maximilians Universität Würzburg, Würzburg/D; ³ Universitätsklinikum Würzburg, Würzburg/D |
| P1.1.18 | Cell on cell – functionally immortalized smooth muscle cells as building blocks for 3D tissues A. Bleisch¹; ¹ InSCREENeX GmbH, Braunschweig/D |
| P1.1.19 | Evaluation of local inflammatory reactions following subcutaneous injection of a pro-inflammatory cocktail in a fully human ex vivo skin model C. Jardet¹; E. Pagès¹; E. Raude²; F. Seeliger³; L. Brandén³; E. Braun¹; M. Ingeslten³; P. Descargues⁴ ¹ GENOSKIN SAS, Toulouse/F; ² LAAS CNRS, Toulouse/F; ³ Drug Safety and Metabolism, iMED Biotech Unit, Astra Zeneca, Gothenburg/S; ⁴ Genoskin Inc., Boston (MA)/USA |
| P1.1.20 | A microchip array-based 3D culture system for the in vitro differentiation of osteoblasts W. Zhang¹; P. Tomakidi²; T. Steinberg²; R. Kohal³; E. Gottwald⁴; B. Altmann¹ ¹ G.E.R.N., Department of Oral and Maxillofacial Surgery, University Medical Center Freiburg, Freiburg im Breisgau/D; ² Department of Oral Biotechnology, University Medical Center Freiburg, Freiburg im Breisgau/D; ³ Department of Prosthetic Dentistry, University Medical Center Freiburg, Freiburg im Breisgau/D; ⁴ 300MICRONS GmbH, Karlsruhe/D |
| P1.1.21 | Automating 3D cell culture using a wood-derived hydrogel L. Paasonen¹; ¹ UPM-Kymmene Corporation, Helsini/FIN |
| P1.1.22 | Combining pluripotent stem cell-derived models of the blood-brain barrier with Multi-Organ-Chip systems L. Koenig¹; A. Ramme¹; D. Faust¹; E. Dehne¹; U. Marx¹; ¹ TissUse GmbH, Berlin/D |
| P1.1.23 | Microspheres-based scaffolds from poly(3-hydroxybutyrate) for 3D cell growth D. Chesnokova¹; I. Zharkova¹; A. Bonartsev¹; V. Voinova¹ ¹ Lomonosov Moscow State University, Faculty of Biology, Moscow/RUS |
| P1.1.24 | In vitro 3D bladder cancer model using PDX-derived cells R. Amaral¹; A. Ma²; H. Zhang²; K. Swiech¹; C. Pan² ¹ University of Sao Paulo, Ribeirao Preto/BR; ² University of California Davis, Sacramento/USA |
Topic |
1.2 Innovative disease models |
|
P1.2.01 |
A tissue engineering approach to model Primary Ciliary Dyskinesia |
|
P1.2.02 |
Characterisation of Bordetella pertussis virulence mechanisms using engineered human airway tissue models |
| P1.2.03 | Establishment and initial characterization of a simple 3D organotypic wound healing model S. Hensler¹; C. Kühlbach²; J. Parente³; S. Krueger-Ziolek⁴; K. Moeller⁴; M. Mueller² ¹ HS Furtwangen, Villingen-Schwenningen/D; ² Molecular Cell Biology Lab, Institute of Technical Medicine, HFU Furtwangen, Villingen-Schwenningen/D; ³ Institute of Technical Medicine, HFU Furtwangen University, Villingen-SChwenningen/D; ⁴ Institute of Technical Medicine, HFU Furtwangen University, Villingen-Schwenningen/D |
| P1.2.04 | Novel 3D tumour models with stromal components to evaluate the efficacy of immunotherapy with gene-engineered ROR1-specific CAR T cells J. Kühnemundt¹ ¹ University Hospital Würzburg, Department of Tissue Engineering & Regenerative Medicine, Würzburg, Germany;, Würzburg/D |
| P1.2.05 | Evaluation of pharmacological responses in InflammaSkin®, a fully human full-thickness ex vivo skin model reproducing key features of psoriatic lesions P. Lovato¹; C. Jardet²; E. PAGES²; A. David²; E. Braun²; H. Norsgaard¹; P. Descargues³ ¹ LEO Pharma, Ballerup/DK; ² GENOSKIN SAS, Toulouse/F; ³ Genoskin Inc., Boston (MA)/USA |
| P1.2.06 | Generation of human induced pluripotent stem cells (hiPSc)-derived hepatocyte organoids to study liver size control E. Saponara¹; ¹ Novartis Institutes of Biomedical Research, Basel/CH |
Topic |
1.3 Complex and multi-cell type models |
|
P1.3.01 |
Using the Real Architecture For 3D Tissue (3D RAFT™) System as a Versatile Tool to Build in vitro Epithelial Barrier Models |
|
P1.3.02 |
Towards a three-dimensional microfluidic in vitro model to assess efficacy & safety of immune-stimulatory antibody drugs |
|
P1.3.03 |
MSCs Isolation in 3D cell culture conditions: challenges, modeling and perspectives. |
|
P1.3.04 |
Retina-on-a-Chip: Merging Organoid and Organ-on-a-Chip technology for complex multi-layer tissue models |
|
P1.3.05 |
WAT-on-a-Chip: Microphysiological systems integrating white adipose tissue |
|
P1.3.06 |
High content screening of intestinal organoid cultures to visualize and quantify immune responses |
|
P1.3.07 |
3D co-cultivation of beta cells and mesenchymal stromal/stem cells for diabetes therapy |
|
P1.3.08 |
Modeling tumor microenvironment to address the dynamics of tumor, stromal and immune cell interactions |
| P1.3.09 | Development of a 3D spheroid SK-MEL-28 tumor model and its characterisation J. Klicks¹; R. Rudolf¹; M. Hafner¹; ¹ Hochschule Mannheim, Mannheim/D |
| P1.3.10 | Trace Amines and Fatty Acids are Essential Endogenous Signaling Factors for β-Cell Activity and Insulin Secretion S. Hauke¹; C. Schultz²; ¹ European Molecular Biology Laboratory (EMBL), Heidelberg/D; ² Oregon Health and Science University (OHSU), Portland, OR/USA |
| P1.3.11 | In vitro vascularization of a human bone marrow model. K. Keskin¹; S. Sieber¹; U. Marx²; R. Lauster¹; M. Rosowski¹ ¹ Technische Universität Berlin, FG Medizinische Biotechnologie, Berlin/D; ² TissUse GmbH, Berlin/D |
| P1.3.12 | Development and characterization of PDX-derived 3D tumor microtissues as platform for screening targeted molecular therapeutics F. Chiovaro¹; N. Buschmann²; I. Agarkova²; A. Maier³; S. Messner²; J. Schueler³; P. Guye²; ¹ InSphero AG, Schlieren/CH; ² Insphero AG, Schlieren/CH; ³ Charles River, Freiburg im Breisgau/D |
| P1.3.13 | Imitation of the long-lived plasma cell survival niche of the human bone marrow in vitro Z. Uyar¹; S. Sieber¹; U. Marx²; R. Lauster¹; M. Rosowski¹ ¹ Technische Universität Berlin |
| P1.3.14 | Development of a Cardiac Organoid Culture System with hiPSC-derived Cardiomyocytes M. Schulze¹ ; B. Ulmer¹ ; M. Lemoine¹ ; A. Fischer¹ ; T. Eschenhagen¹; ¹ University Medical Center Hamburg-Eppendorf |
| P1.3.15 | Neuronal differentiation of human iPSCs in 3DProSeed hydrogel well plate and establishment of glia co-cultures S. de Leeuw¹; V. Milleret²; B. Simona³; R. Urbanet²; M. Ehrbar²; C. Tackenberg¹ ¹ Institute for Regenerative Medicine, University of Zürich, Schlieren/CH; ² Department of Obstetrics, University hospital Zürich, Zürich/CH; ³ Ectica Technologies AG, Zürich/CH |
| P1.3.16 | Contractile work contributes to maturation of energy metabolism in hiPSC-derived cardiomyocytes B. Ulmer¹; A. Stoehr²; M. Schulze¹; S. Patel³; M. Gucek³; I. Mannhardt¹; S. Funcke¹; E. Murphy³; T. Eschenhagen¹; A. Hansen¹ ¹ UKE, Hamburg/D; ² Karolinska Institutet, Huddinge/S; ³ National Heart Lung and Blood Institute, Bethesda/USA |
| P1.3.17 | Development of microvascular structures inside porous fibrin coated polydioxanon and PLLA/PLGA scaffolds S. Heene¹; S. Thoms¹; R. Jonczyk¹; T. Scheper¹; C. Blume¹ ¹ Leibniz Universität Hannover, Hannover/D |
Topic |
1.4 Predictivity and validation |
|
P1.4.01 |
Patient-derived 3D tumor cultures for clinical diagnostics and pre-clinical drug development. |
|
P1.4.02 |
Detailed Cell-Material Interactions in 3D Cell Culture Systems |
|
P1.4.03 |
Towards controlling the mobility of flowing cells in a hanging-drop network for microphysiological systems |
Topic |
2.1 Translation of models to solutions |
|
P2.1.01 |
Three-dimensional in vitro co-culture model for nanoparticle-mediated transfection |
|
P2.1.02 |
Microphysiological system based on human liver microtissues for intrinsic clearance prediction |
Topic |
2.2 Clinical applications |
|
P2.2.01 |
Silencing GALNT1 or GALNT2 suppresses malignant phenotypes of pancreatic cancer cells |
|
P2.2.02 |
Production of clinical grade temporary epidermal substitute obtained from hESC derived keratinocytes for the treatment of sickle cell leg ulcers: a challenge for regenerative medicine |
| P2.2.03 | Establishment of a Novel Functional in Vitro Assay to Investigate the Angiogenic Potential of Colonic Adenocarcinomas S. Bring Truelsen¹; G. Hagel¹; N. Mousavi²; H. Harling²; K. Qvortrup²; O. Thastrup¹; J. Thastrup¹ ¹ 2cureX A/S, Birkerød/DK; ² University of Copenhagen, Copenhagen/DK |
TOPIC |
3.1 Innovative, advanced analytics |
| P3.1.01 | Imaging oxygen gradients in cell aggregates and in spheroids R. Meier¹; R. Meier¹; ¹ PreSens Precision Sensing GmbH, Regensburg/D |
| P3.1.02 | Application of video analysis for the evaluation of cardiac contractility in different in vitro model systems including freshly isolated adult rat cardiomyocytes and human iPSC-derived cardiomyocytes in 2D- and 3D-culture P. Beauchamp¹; S. Adrian²; S. Longnus²; T. Suter²; C. Zuppinger³ ¹ Bern University, Bern/CH; ² Bern University Hospital, Bern/CH; ³ University Hospital Bern, Bern/CH |
Topic |
3.2 Specific assay development |
|
P3.2.01 |
Microfluidics: a powerful tool to recreate in vivo environment |
|
P3.2.02 |
An assay to characterize the impact of cigarette smoke exposure on mucociliary clearance in-vitro. |
|
P3.2.03 |
Minimalistic hydrogel matrices to direct early neural progenitors from pluripotent stem cells in 3D culture |
|
P3.2.04 |
Real-Time Assay for Apoptosis using Complementation of Annexin V Luciferase Subunits |
|
P3.2.05 |
Benefits of Real-Time Measurements of Cell Health in 2D or 3D Using a Plate Reader |
|
P3.2.06 |
Volume Regulation of HaCaT Spheroids in Response to Hypotonic Stimuli |
|
P3.2.07 |
Calcium signals in taste-bud like 3D cultures |
Topic |
3.3 New devices for 3D cell culture |
|
P3.3.01 |
Scaffold-Free Aggregate Cultivation of Mesenchymal Stem Cells in a Stirred Tank Bioreactor |
|
P3.3.02 |
Guiding 3D cell migration in deformed synthetic hydrogel micro-structures |
|
P3.3.03 |
Scaffold-Free Aggregate Cultivation of Mesenchymal Stem Cells in a Stirred Tank Bioreactor |
|
P3.3.04 |
Development, Characterization and Application of a Parallelizable Perfusion Bioreactor for 3D Cell Culture |
|
P3.3.05 |
A modular perfusion microbioreactor system for oxygen level control and optimization for bone tissue engineering |
|
P3.3.06 |
Gelatin-based hydrogels for 3D cell culture: stability at physiological temperatures by UV-crosslinking or nanoparticles |
|
P3.3.07 |
A tubing-free, microfluidic tilting platform for the realization of in vivo-like drug exposure scenarios for three-dimensional microtissues |
|
P3.3.08 |
Organ-on-a-Disc – Enabling technology for the parallelization and automation of microphysiological systems |
|
P3.3.09 |
Porous, ultralight 3D tubular scaffolds from short electrospun nanofibers |
|
P3.3.10 |
Enhanced cardiomyocyte maturation in a microfluidic system as a potential platform for pharmacological screening |
|
P3.3.11 |
Autonomous Plug&Play Multi-Organ-Chips with Integrated Pumping and Sensing |
|
P3.3.12 |
vasQchip: A blood vessel scaffold for the reconstruction and 3D bioprinting of 3D-tissues in vitro |
|
P3.3.13 |
A non-invasive microscopy platform for the online monitoring of human induced pluripotent stem cell aggregation in suspension cultures in small-scale stirred tank bioreactors |
|
P3.3.14 |
Comparison of 2D and 3D cultures of primary hepatocytes on hepatocellular functions and hepatotoxicity |
| P3.3.15 | Funnel-Guided Positioning of Multi-cellular Microtissues to Build Macrotissues K. Manning¹; A. Thomson²; J. Morgan² ¹ Brown University, Providence, RI/USA; ² Brown University, Providence/USA |
| P3.3.16 | A novel 3D microwell array for analysis of adhesion independent micro-tumours A. Thomsen¹; C. Aldrian²; Y. Thomann³; A. Grosu²; P. Bronsert⁴; M. Leu⁵; P. Lund⁶ ¹ University Medical Center Freiburg, Freiburg/D; ² Medical Center – University of Freiburg, Freiburg/D; ³ Freiburg Material Research Center and Institute for Macromolecular Chemistry, Freiburg/D; ⁴ Institute for Surgical Pathology, Medical Center – University of Freiburg, Freiburg/D; ⁵ abc biopply ag, Solothurn/CH; ⁶ Department of Radiation Oncology, Ortenau-Klinikum, Offenburg/D |
| P3.3.17 | Integration of 3d printed hollow hydrogel fiber with microfluidic system to develop a perfusable nephron model. A. Akkineni¹; D. Förster²; J. Sardnick²; F. Schmieder³; F. Sonntag³; M. Gelinsky¹; A. Lode¹ ¹ Centre for Translational Bone, Joint and Soft Tissue Research, TU Dresden, Dresden/D; ² University Hospital Carl Gustav Carus, TU Dresden, Dresden/D; ³ Fraunhofer Institute for Material and Beam Technology IWS, Dresden/D |
Topic |
3.5 High-throughput and automatisation |
|
P3.5.01 |
Impedance analysis of viability of Schistosoma mansoni larvae for drug screening application |
|
P3.5.02 |
Magnetic 3D Bioprinting for High-Throughput and Automated Hepatotoxicity Testing |
|
P3.5.03 |
Cytotoxicity Evaluation of Nanoparticles using Automatic 3D Cell Culture System |
|
P3.5.04 |
Automated large-scale production and deposition of spheroids |
Topic |
3.6 3D printing |
|
P3.6.01 |
Characterization of GelMa and alginate hydrogels for bioprinting: |
|
P3.6.03 |
Engineering bio-mimetic vasculature with photolithographic |
|
P3.6.04 |
Characterisation of bioprinted mandibular osteoblasts for engineering an |
|
P3.6.05 |
3D Bioprinting of hydrogels for viral Infection and transduction with |
|
P3.6.06 |
3D-printed drug delivery systems for cell therapy: |
|
P3.6.07 |
Imaging of O2 concentration and spatial distribution in |
| P3.6.08 | Modelling of a microfluidic device to study tumor cell extravasation C. Kühlbach¹; R. Glunz¹; M. Mueller¹; F. Baganz²; V. Hass¹ ¹ HFU Hochschule Furtwangen University, Villingen-Schwenningen/D; ² UCL University College London, London/UK |